Delivery Order SPE2DB22D1202-SPE2DB24FUZE6
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Enbrel 50 mg/ml SureClick medication to DLA Troop Support Medical facilities. The $7,187.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 19, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a...
- The federal contract award is for the delivery of Enbrel 50 mg/mL SureClick, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $27,893.77, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price under the DLA's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which runs through November 2026. The contract does not have a...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $56,647.25 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick medication to the Defense Logistics Agency (DLA). The single-award, indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is valued at up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award is for the delivery of Enbrel 50 mg/ml SureClick medication to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $11,638.80, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of March 18, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $15,329.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the delivery of Enbrel 50 mg/mL SureClick medication. The award has a ceiling value of $25,066.61 and a completion date of May 3, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of Enbrel 50 mg/mL SureClick medication to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $81,166.80 and runs through September 15, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The $13,022.74 firm fixed-price delivery order contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Enbrel 50 mg/mL SureClick medication. The $31,213.08 firm fixed-price delivery order contract has a performance period through January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for supplying a comprehensive range of...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUZE6Delivery Order
This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,551.54 and runs through May 3, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 5/2/24 |